Kingworld Medicines Group (HKSE:01110) Change In Receivables : HK$0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Kingworld Medicines Group Change In Receivables?

Kingworld Medicines Group's change in receivables for the quarter that ended in Dec. 2023 was HK$0 Mil. It means Kingworld Medicines Group's Accounts Receivable stayed the same from Jun. 2023 to Dec. 2023 .

Kingworld Medicines Group's change in receivables for the fiscal year that ended in Dec. 2023 was HK$6 Mil. It means Kingworld Medicines Group's Accounts Receivable declined by HK$6 Mil from Dec. 2022 to Dec. 2023 .

Kingworld Medicines Group's Accounts Receivable for the quarter that ended in Dec. 2023 was HK$129 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Kingworld Medicines Group's Days Sales Outstanding for the six months ended in Dec. 2023 was 40.88.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Kingworld Medicines Group's liquidation value for the six months ended in Dec. 2023 was HK$-325 Mil.

Kingworld Medicines Group Change In Receivables Historical Data

The historical data trend for Kingworld Medicines Group's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kingworld Medicines Group Change In Receivables Chart

Kingworld Medicines Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

28.02

79.57

-14.08

55.92

6.18

Kingworld Medicines Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Kingworld Medicines Group Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

Kingworld Medicines Group (HKSE:01110) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Kingworld Medicines Group's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	128.779	/	574.936	*	91
=	40.88

2. In Ben Graham's calculation of liquidation value, Kingworld Medicines Group's accounts receivable are only considered to be worth 75% of book value:

Kingworld Medicines Group's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	212.225	-	698.157	+	0.75 * 128.779	+	0.5 * 128.659
=	-325

Kingworld Medicines Group Change In Receivables Related Terms

Thank you for viewing the detailed overview of Kingworld Medicines Group's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Kingworld Medicines Group (HKSE:01110) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kingworld Medicines Group Ltd (HKSE:01110) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

198 Daxin Road, 8th-9th Floor, Block A, Majialong Chuangxin Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518016

Website

https://www.kingworld.com.cn

Kingworld Medicines Group Ltd is engaged in Distribution sales of pharmaceutical and healthcare products such as branded imported pharmaceutical and healthcare products primarily in Hong Kong and the PRC, and Manufacturing and sales of electrotherapeutic and physiotherapeutic devices and general medical examination devices primarily carried out in the PRC. It derives the majority of its revenue from Distribution sales of pharmaceutical and healthcare products segment.

Kingworld Medicines Group (HKSE:01110) Headlines

No Headlines